Key facts
| Price (PPV) | 990 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ténofovir alafénamide |
| Class | Antivirals for systemic use |
| ATC code | J05AF13 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boite de 30 |
| Hospital price | 710 MAD |
| Data collected on | 9/8/2026 |
Indications
Vemlidy est indiqué pour le traitement des adultes atteints d'hépatite B chronique présentant une maladie hépatique compensée.
Find an open pharmacy
On-call pharmacies near you
About Vemlidy 25 mg
Vemlidy 25 mg belongs to the antivirals for systemic use therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Vemlidy 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Vemlidy 25 mg
Answers to common questions from Moroccan patients about this drug.